This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Sudden budget changes can derail plans. Learn practical coping strategies to maintain balance and avoid unnecessary debt.
13,459 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A two-day injunction hearing opens in federal court in Chicago as Zillow fights to keep access to the Chicagoland MLS...
New retirement spending data shows older savers reduce outlays as healthcare costs rise, signaling a shift in plannin...
A federal judge granted Alibaba a temporary reprieve from the Defense Department lobbying ban as she weighs the compa...
A new push from across the political spectrum asks whether the public should share in AI profits. This article breaks...
The IMF slashed its 2026 global growth forecast to 3.0% amid the Iran conflict, but AI-driven investment and technolo...
A coalition of housing groups is pressing the FHFA to delay and rewrite proposed condo-loan changes from Fannie Mae a...
Applied Optoelectronics surged 251% year-to-date on soaring AI data-center demand, while the Invesco Semiconductors E...
Micron stock has swung on memory cycles, auto-chip demand, and big backlog talk. This article examines whether a deal...
A new tax window in 2026 may allow a retired couple to realize nearly six figures in long-term gains without federal ...
President Trump signed proclamations shrinking Bears Ears and Grand Staircase-Escalante monuments by roughly 90%, sig...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...